Thursday, December 17, 2020

Bharat Biotech's Covaxin safe, says Phase 1 trial data

The results of Phase 1 results of Covaxin had not been publicly released yet even though the data was first presented to Drugs Controller General of India (DCGI) on October 2 when the company applied for approval to start Phase 3 trials.

Posted from: this blog via Microsoft Flow.

No comments:

Post a Comment